Biden行政当局提议扩大对减重药物的医疗保险和医疗补助的覆盖面,援助数百万人。 Biden administration proposes expanding Medicare and Medicaid coverage for weight-loss drugs, aiding millions.

拜登政府提议扩大对Wegovy和Zepbound等减重药品的医疗保险和医疗补助的覆盖面,使340万医疗补助和400万医疗补助注册者能够获得这些药品。 The Biden administration proposes to expand Medicare and Medicaid coverage for weight-loss drugs like Wegovy and Zepbound, making them accessible to 3.4 million Medicare and 4 million Medicaid enrollees. 这项提案可能会在十年内造成纳税人350亿美元的损失,但有可能遭到反对毒品的罗伯特·肯尼迪(Robert F. Kennedy Jr)的反对。 The proposal, which could cost taxpayers $35 billion over a decade, faces potential opposition from Robert F. Kennedy Jr., who opposes the drugs. 该规则如果实施,可将自付费用减少高达95%,目的是预防与肥胖有关的慢性病。 The rule, if implemented, could reduce out-of-pocket costs by up to 95% and aims to prevent chronic conditions related to obesity.